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Adverse local tissue reaction associated with total hip replacement may occur when mechanically
assisted crevice corrosion occurs at metal-metal modular junctions in which at least one of the com-
ponents is fabricated from cobalt-chromium alloy. Complete removal of components may be associated
with signiﬁcant morbidity; when components are well ﬁxed and in acceptable position, it may be
appropriate to consider modular rather than complete revision. We have diagnosed mechanically
assisted crevice corrosion in total hip arthroplasty patients with noncontemporary but well-ﬁxed
femoral components and found that modular conversion to a ceramic femoral head to remove a
source of CoCr corrosion and fretting products was only possible by having a custom titanium sleeve
manufactured. Surgical implantation with a revision style Biolox ceramic head (CeramTec, Plochingen,
Germany) was then achieved.
Copyright © 2015 The Authors. Published by Elsevier Inc. on behalf of American Association of Hip and
Knee Surgeons. This is an open access article under the CC BY-NC-ND license (http://creativecommons.
org/licenses/by-nc-nd/4.0/).Introduction
Serious adverse local tissue reactions (ALTRs) have become
associated with metal-on-metal (MoM) joint failures, modular
femoral neck components, and more recently, mechanically assis-
ted crevice corrosion (MACC) at the taper interface of metal-on-
polyethylene (MoP) total hip replacements [1-3]. Although some
contemporary surgeries seem to have a higher prevalence of this
issue [1], nonmodern implants may also fail in this manner,
particularly after many years in service or after prior femoral head
revision.
We present an approach to patients with MACC and
noncontemporary total hip arthroplasties (THAs). When only
“off-the-shelf” cobalt-chromium (Co-Cr) alloy femoral headclosed potential or pertinent
ent, either direct or indirect,
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es/by-nc-nd/4.0/).options for revision of their well-ﬁxed femoral components are
available, we describe commissioning a custom titanium sleeve
to be made that could be used with an already manufactured
Biolox ceramic femoral head (CeramTec, Plochingen, Germany)
to remove the source of Co alloy at revision. In our experience,
metal ion levels decrease postoperatively, and patients are
satisﬁed and improved at follow-up. This is the ﬁrst report, to
our knowledge, that describes the use of a custom titanium
sleeve for surgical treatment of MACC in conjunction with a
well-ﬁxed nonmodern stem in THA.Surgical technique
Once revision THA for MACC is contemplated, the exact
implant is researched, preferably by obtaining the implant
identiﬁcation stickers. The manufacturer is then contacted to
conﬁrm the availability of a revision femoral head other than one
made from a Co alloy (eg, ceramic with a titanium revision sleeve,
BioBall Adapter System, and ceramic head [Merete, Germany] or
zirconium alloy metal substrate that transitions into a ceramic
zirconium oxide outer surface [Oxinium; Smith & Nephew, Inc.,
Memphis, TN]).an Association of Hip and Knee Surgeons. This is an open access article under the CC
Table 1
General process for obtaining manufacture of a custom titanium sleeve to allow
implantation with a revision style Biolox ceramic head (CeramTec, Plochingen,
Germany).
Conﬁrm that ceramic or Oxinium (Smith& Nephew, Inc., Memphis, TN) revision
femoral head component is not currently available for ﬁxed femoral stem.
Request prosthesis trunnion speciﬁcations from femoral stem manufacturer.
Conﬁrm that the custom titanium sleeve will work with implanted prosthesis
(ﬁxed femoral stem).
Obtain an assessment from a physician (orthopaedic surgeon) who is not biased
concurring with plan to use the custom component.
Obtain compassionate use device documentation through hospital or practice
IRB if indicated.
Submit device description including planned neck length and head size (Special
products Implant Request Form).
Review manufacturing plan.
Forward purchase order to manufacturer for two devices (in case second urgent
surgery is needed or the ﬁrst implant is contaminated).
Obtain patient consent after reviewing risks, beneﬁts, goals, and alternatives.
Sign informed risk document for surgery.
Proceedwith surgery when device is available but have appropriate backup plan
for revision if device is not suitable.
Figure 1. Anteroposterior pelvis radiograph of a 52-year-old man with a revision
metal-on-polyethylene bearing surface THA and new diagnosis of MACC. The acetab-
ulum and femoral stem appear to be well ﬁxed. Osteolysis associated with his prior
surgery has not increased over time.
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and well-positioned femoral component, we have requested a
custom titanium sleeve to bemanufactured thatworks in conjunction
with an “off-the-shelf” revision Biolox ceramic femoral head (Biolox
Option; CeramTec, Plochingen, Germany).We have requested that the
femoral stemmanufactures make this product, as they have the exact
speciﬁcations of the femoral trunnion. Table 1 summarizes the steps
necessary to manufacture such a custom product. Note that if the
company has made <5 such custom products in the last year, the
Federal Food, Drug, and Cosmetics act was amended to allow the
company to manufacture these for compassionate use without
institutional review board approval. Our institutional review board,
however, noted that the Food and Drug Administration recommends
that physicians should follow as many of the patient protection pro-
cedures as possible (Table 2).
Of note, the surgeon should consider the exact femoral neck
length that is being sought whenmanufacturing the custom sleeve.
We choose the same or slightly longer length of the implanted neck
if the leg length is acceptable to ensure stability at the time of
revision. Also, we have had two sleeves per patient made, in case
one is inadvertently contaminated during surgery or a repeat
revision is needed.
The technique itself is exactly as for the Biolox Option (Ceram-
Tec, Plochingen, Germany) technique [4]. The ceramic femoral head
is placed on the head adapter, and pressure is applied until resis-
tance is felt. The ceramic femoral head must be placed straight
down on the sleeve. The system components are then assembled on
the femoral stem; no washing or cleaning is necessary.
Case example
The patient is a 52-year-old man who reported newly onset
groin and buttock pain of the left hip 18 years after total hipTable 2
Patient protection procedures recommended by the Food and Drug Administration
for use of a custom device in joint replacement surgery.
Informed consent from the patient or a legal representative.
Clearance from the institution as speciﬁed by institutional policies.
Concurrence by the IRB chairperson.
Assessment from a physician (orthopaedic surgeon) who is not biased
concurring with plan to use the custom component.
Authorization from the investigational device exemption (IDE sponsor) if an IDE
exists for the device.replacement surgery for osteonecrosis and 5 years postrevision
total hip replacement for instability. A 36-mm, medium-plus Co-Cr
head was used on the 6 taper of the patient's titanium ﬁber metal
ingrowth stem (Zimmer, Inc., Warsaw, IN). Physical examination of
the patient demonstrated no gait impairment, and abductor
strength was found to be satisfactory. Medical history was positive
for diabetes mellitus, type 1.
Radiographic examination showed no obvious evidence of
osteolysis or loosening and that hip components were satisfactorily
positioned. The calcar osteolysis associated with his prior surgery
had not increased (Fig. 1). Laboratory tests conducted approxi-
mately 3 months after the onset of hip pain revealed serum Co (2.2
ppb; normal, <0.3 ppb) and Cr (2.4 ppb; normal, 0.0-0.9 ppb) ions
in the blood. Complete blood count revealed a white blood cell
count of 5600 cells/mm3 (normal, 4200-9900); C-reactive protein
was found to be normal at 0.9 mg/L (normal, 0.0-8.0 mg/L), as was
erythrocyte sedimentation rate at 8 mm/h (normal, 0-10 mm/h).
Axial, coronal, and sagittal sequencing performed using metal
artifact reduction sequence magnetic resonance imaging found noFigure 2. Drawing sent for surgeon approval of a custom titanium sleeve.
Figure 3. Intraoperative photograph of blackened trunnion associated with MACC (a), trunnion after cleaning and removal of discolored material (b), placement of a custom
titanium sleeve onto the cleaned trunnion (c), and placement of Biolox Option (CeramTec, Plochingen, Germany) ceramic femoral head (d).
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heterogeneous ﬂuid detected in the periprosthetic soft tissues
anteriorly measuring 1  1.8 cm, with no decomposition into the
trochanteric or iliopsoas bursa. No evidence was found of muscle
edema or tear of the muscle detachment. Joint aspiration demon-
strated very high Co and Cr levels of 322 and 598.8 ppb, respec-
tively. Gram stain and culture showed no bacteria present.
MACC of the trunnion was diagnosed. After shared decision-
making discussion, the patient opted for revision surgery of his
well-ﬁxed, well-positioned total hip replacement. After contacting
Zimmer, Inc. (Warsaw, IN), it was determined that a non-Co alloy
head was not available for the 6 taper of the stem, so a custom
titanium sleeve for use with a Biolox Option ceramic head was
commissioned (Fig. 2).
At surgery, MACC was conﬁrmed with black discoloration and
debris of the trunnion and inside of the femoral head (Fig. 3a). The
trunnionwas cleaned (Fig. 3b) after irrigation and debridement and
polyethylene revision to treat third-body debris [5]. The sleeve was
placed on the clean trunnion (Fig. 3c) until resistance was felt. The
ceramic femoral head was then placed straight down on the sleeve
and impacted as per the Zimmer protocol [4] (Fig. 3d). The hip wascarefully reduced, and the hip capsule was reconstructed before
closure. The patient recovered and is pain free with full function at
3 months postoperatively (Fig. 4). Serum Co is undetectable and
serum Cr is 1.9 ppb.
Discussion
MACC has been linked to a number of adverse outcomes in THA,
including mechanical deﬁciency of the implant and ALTRs or
adverse reaction to metal debris, so-called “pseudotumor” forma-
tion, osteolysis, and muscle and tissue necrosis and deﬁciency
[1-3]. Development of appropriate diagnosis and treatment
guidelines for MACC is important, but until these are available,
minimizing patient morbidity while removing or minimizing the
intra-articular and serum Co and Cr metal ions seems prudent. This
technique may be considered in select patients, where removal of a
well-ﬁxed, well-positioned stem is difﬁcult or unwise, and the stem
is noncontemporary without an option of an “off-the-shelf” non-Co
alloy replacement head.
Our current deﬁnition of MACC agrees with that recently re-
ported by the Rush University group [3]. They found that patients
Figure 4. Anteroposterior pelvis radiograph of the patient after revision using a
custom titanium sleeve for conversion to a ceramic femoral head.
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implants are well ﬁxed and infection has been ruled out, should be
evaluated with serum Co and Cr levels. Because previous work
from their institution suggested that the serum Co level should be
<1 ppb in a well-functioning THA with a MoP bearing [6], they
used a Co level of >1 ppb as a diagnostic cutoff. We have also found
that intra-articular serum levels of Co and Cr, although not
mandatory, can be helpful in conﬁrming MACC. We have found
that they are commonly elevated 50 to 100 times or more the
serum levels.
The Co-to-Cr ratio may also be helpful but is not pathogno-
monic. Although Plummer et al. [3] found that the abnormal serum
Co level was signiﬁcantly elevated above the serum Cr level (by a
mean 11-to-2 ppb ratio) in MACC, less dramatic but asymmetrical
ratios have been described with MoM total hip replacements [7,8].
On the other hand, the patient diagnosed with MACC presented
here had a Co:Cr ratio of approximately 1, although his implant was
a MoP articulation. Furthermore, Fehring et al. [9] have found that
the Co:Cr ratio is not a predictive biomarker for ALTRs (they looked
at MoM total hip replacement only.)
The logic of using only a ceramic head with a titanium sleeve in
revision settings is based on manufacturer recommendations [10],
and the fact that deformed areas of the previously used taper may
create stress risers that can lead to ceramic crack initiation and
propagation [11]. Although placement of a ceramic head directly on
an undamaged but previously used trunnion has been successful at
short-term follow-up in one study of 61 hips [11], case reports of
ceramic head fracture in this situation have been reported [12,13].
Conversely, we could ﬁnd no reports of a fractured third-generation
ceramic head used with a revision sleeve, and the fracture rate forBiolox femoral heads (CeramTec, Plochingen, Germany) manufac-
tured after 1994 has been reported to be 0.004% [10].
A thorough discussion with the patient before accepting the
risks associated with the use of a custom implant should be un-
dertaken. The patient should understand the risk of ceramic frac-
ture and the ramiﬁcations of such a fracture. In cases where the
well-ﬁxed stem is made from a Co alloy, MACC may theoretically
continue despite removing the Co alloy femoral head. On the other
hand, the technique of revising the femoral head only, even for Co-
Cr stems, is successful at signiﬁcantly reducing serum Co and Cr
levels at an average of 2.7 years [3]. Next, there are signiﬁcant
challenges for the surgeon in pursuing this approach including
painstaking preoperative workup and the need for multiple surgi-
cal plans if the custom implant does not ﬁt properly or instability is
noted after reconstruction.Summary
ALTR associated with MACC occurs at metal-metal modular
junctions inwhich at least one of the components is fabricated from
Co-Cr alloy. Complete removal of THA components may be associ-
ated with signiﬁcant morbidity, and it may be appropriate to
consider modular rather than complete revision in select patients.
We describe the surgical technique of using a custom titanium
sleeve with an “off-the-shelf” revision style Biolox ceramic head
(CeramTec, Plochingen, Germany) for revision THA for MACC.References
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